SOA Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
CWP
FWIA
ORIO
CNB
KC
SOA Wealth Advisors's PFE Position: Q2 2026 in Review
SOA Wealth Advisors reduced its Pfizer (PFE) stake by 20% in Q2 2026, selling an estimated $38.7K and leaving 5,991 shares worth $144K. The position accounts for 0.02% of the portfolio, ranked #248.
SOA Wealth Advisors first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $854K in Q4 2021. 632 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- SOA Wealth Advisors held 5,991 shares of Pfizer worth $144K as of Q2 2026.
- SOA Wealth Advisors sold 1,481 Pfizer shares in Q2 2026, an estimated $38.7K.
- Pfizer made up 0.02% of SOA Wealth Advisors's portfolio in Q2 2026, its #248 holding.
- SOA Wealth Advisors first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
- SOA Wealth Advisors's Pfizer position peaked at $854K in Q4 2021.
- 632 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on SOA Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.